Lord Taylor of Warwick
Non-affiliated
To ask Her Majesty’s Government what plans they have to improve lung cancer therapy available on the NHS in the light of the recent trial of Nivolumab.
Lord Prior of Brampton
The Parliamentary Under-Secretary of State, Department of Health
Nivolumab for previously treated locally advanced or metastatic non-small cell lung cancer was referred to the National Institute for Care Excellence (NICE) in March 2015. The development of the appraisal is expected to start shortly, and NICE is anticipating final guidance to be issued in May 2016.
Does this answer the above question?
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.